Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Additionally, significant intergroup differences were observed in CACS, age, sex, history of diabetes, body mass index, urea clearance index, hemoglobin, serum albumin, serum ferritin, CRP, serum phosphorus, parathyroid hormone, 25-hydroxyvitamin D, and alkaline phosphatase levels (Table 1).
Source: General demographic characteristics and clinical biochemical indicators. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Case-control study.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
A case-control study was conducted involving 76 patients with CKD Stage 5D undergoing MHD.
Source: Abstract.
Based on the classification guidelines established by the American Heart Association, participants were categorized into three groups based on their CACS: Group 1: CACS < 100 (non-calcified group), Group 2: 100 ≤ CACS ≤ 400 (low-score calcification group), and Group 3: CACS > 400 (high-score calcification group).
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Association Between Serum SFRP1 Levels and Coronary Artery Calcification in Stage 5D Chronic Kidney Disease Undergoing Maintenance Hemodialysis
Case-control study · Physiological Research · 2026
Original publication title
Association Between Serum SFRP1 Levels and Coronary Artery Calcification in Stage 5D Chronic Kidney Disease Undergoing Maintenance Hemodialysis
© 2026 by the authors
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
Summary
This study aimed to examine the association between serum Secreted Frizzled-Related Protein 1 (SFRP1) levels and the presence of coronary artery calcification (CAC) in patients with Stage 5D chronic kidney disease (CKD) undergoing maintenance hemodialysis (MHD). A case-control study was conducted involving 76 patients with CKD Stage 5D undergoing MHD. Participants were stratified into three groups based on Coronary Artery Calcium Scores (CACS): non-calcified (CACS < 100), low-score calcification (100 ≤ CACS ≤ 400), and high-score calcification (CACS > 400).
Serum concentrations of SFRP1, hemoglobin, albumin, ferritin, C-reactive protein (CRP), calcium, phosphorus, 25-hydroxyvitamin D, and intact parathyroid hormone were measured. Correlations between biochemical parameters and CAC were evaluated, and multivariate linear regression analysis was employed to identify independent risk factors for CAC. CAC was detected in 60.5 % of the study population. Serum SFRP1 concentrations were significantly elevated in the high-score calcification group compared to both the low-score and non-calcified groups, with the lowest levels observed in the non-calcified group (p < 0.01).
Positive correlations were observed between CAC and serum levels of SFRP1 levels, phosphorus, age, hemoglobin, alkaline phosphatase, and age. Multivariate linear regression analysis identified serum SFRP1 and phosphorus levels as independent risk factors for CAC in this population (p < 0.05). Receiver operating characteristic (ROC) curve analysis demonstrated that serum SFRP1 levels yielded an area under the curve (AUC) of 0.898 (95 % CI: 0.826 to 0.970, p < 0.0001) for predicting CAC, with a Youden index of 0.738 at a cut-off value of 4.242 ng/ml.
Elevated serum SFRP1 levels were associated with an increased likelihood of CAC in patients with Stage 5D CKD undergoing MHD. These findings suggest that SFRP1 may represent a potential biomarker for identifying patients at risk for CAC in this population.
Authors’ abstract
Summary
This study aimed to examine the association between serum Secreted Frizzled-Related Protein 1 (SFRP1) levels and the presence of coronary artery calcification (CAC) in patients with Stage 5D chronic kidney disease (CKD) undergoing maintenance hemodialysis (MHD). A case-control study was conducted involving 76 patients with CKD Stage 5D undergoing MHD. Participants were stratified into three groups based on Coronary Artery Calcium Scores (CACS): non-calcified (CACS < 100), low-score calcification (100 ≤ CACS ≤ 400), and high-score calcification (CACS > 400).
Serum concentrations of SFRP1, hemoglobin, albumin, ferritin, C-reactive protein (CRP), calcium, phosphorus, 25-hydroxyvitamin D, and intact parathyroid hormone were measured. Correlations between biochemical parameters and CAC were evaluated, and multivariate linear regression analysis was employed to identify independent risk factors for CAC. CAC was detected in 60.5 % of the study population. Serum SFRP1 concentrations were significantly elevated in the high-score calcification group compared to both the low-score and non-calcified groups, with the lowest levels observed in the non-calcified group (p < 0.01).
Positive correlations were observed between CAC and serum levels of SFRP1 levels, phosphorus, age, hemoglobin, alkaline phosphatase, and age. Multivariate linear regression analysis identified serum SFRP1 and phosphorus levels as independent risk factors for CAC in this population (p < 0.05). Receiver operating characteristic (ROC) curve analysis demonstrated that serum SFRP1 levels yielded an area under the curve (AUC) of 0.898 (95 % CI: 0.826 to 0.970, p < 0.0001) for predicting CAC, with a Youden index of 0.738 at a cut-off value of 4.242 ng/ml.
Elevated serum SFRP1 levels were associated with an increased likelihood of CAC in patients with Stage 5D CKD undergoing MHD. These findings suggest that SFRP1 may represent a potential biomarker for identifying patients at risk for CAC in this population.
Publication and source details
Original title: Association Between Serum SFRP1 Levels and Coronary Artery Calcification in Stage 5D Chronic Kidney Disease Undergoing Maintenance Hemodialysis
Huihui CHEN; Jingjing JIN; Meijuan CHENG; Zhezhe NIU; Shenglei ZHANG; Yaling BAI; Guolei ZHANG; Jinsheng XU
Physiological Research · 2026
Corresponding authors: Jinsheng Xu, Department of Nephrology, the Fourth Hospital of Hebei Medical University, 12 Jian kang Road, Shijiazhuang, 050011, P. R. China, E-mail: 46400262@hebmu.edu.cn; Guolei Zhang, Department of Orthopedics, the Third Hospital of Hebei Medical University, No.139 Ziqiang Road, Shijiazhuang 050051, China, E-mail: 93347388@qq.com© 2026 by the authors2026https://creativecommons.org/licenses/by/4.0/An open access article under the CC BY 4.0 license https://creativecommons.org/licenses/by/4.0/2023 key subject of medical science research in Hebei Province20230112Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T23:16:42.694561+00:00
DOI: 10.33549/physiolres.935693 · PMC13225440